Catch up on today’s top five analyst upgrades with this list compiled by The Fly: 1. Quest Diagnostics (DGX) resumed to Buy from Hold at Deutsche Bank with analyst Pito Chickering assuming coverage of the stock and saying routine testing is rebounding faster than expected and the COVID-19 testing addressable market is greater than appreciated. 2. Lowe’s (LOW) was upgraded to Buy from Hold at Gordon Haskett while RH (RH) was upgraded to Hold from Reduce. 3. Eaton Vance (EV) upgraded to Buy from Neutral at BofA with analyst Michael Carrier citing the company’s attractive outlook for margins and cash flow driven by “Parametric, Calvert, and EV Fixed Income” in spite of the floating rate headwinds. 4. Grainger (GWW) upgraded to Buy from Neutral at Longbow with analyst Chris Dankert saying his survey work suggests demand has bottomed during April and May as end customer locations are opening up. 5. AbbVie (ABBV) upgraded to Buy from Hold at Argus with analyst David Toung saying after its completed merger with Allergan, the company’s new portfolio includes a “growing oncology franchise anchored by Imbruvica and Venclexta and two growth drivers in the immunology space – Skyrizi and Rinvoq.” This list is just a portion of The Fly’s full analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)
previous post
next post